BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Heart
,
Pharmacogenetics
,
Quercetin
,
rs7903146
,
SLC12A1
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
olopatadine
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
HRH1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
Histamine H1 receptor
eosinophil migration
regulation of vascular permeability
G-protein coupled serotonin receptor signaling pathway
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Stereoselective syntheses of the antihistaminic drug olopatadine and its E-isomer.
Fixed drug eruption induced by topical olopatadine ophthalmic solution.
Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-in…
Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis.
The effect of antihistamines on seizures induced by increasing-current electroshocks: ketotifen, but…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Olopatadine on Allergic Tear Mediators
Olopatadine Eye Drops and Allergy Skin Testing
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ